Events & conferences in the Life Sciences industry

Four Seasons Hotel
San Francisco USA

East/West CEO: For CEOs about the run the gauntlet of the JP Morgan Healthcare Conference, prepare your game plan and leverage the experience of your peers at this invitation-only, off-the-record event taking place January 11-12, 2020 in San Francisco. This meeting will convene senior-level executives to discuss the most pressing issues facing the industry. Keynote speakers include Chris Gibson, Founder & CEO of Recursion Pharmaceuticals, Marianne De Backer, EVP Global Head of BD & Licensing of Bayer Pharmaceuticals, Brian Wallach, Co-founder of I AM ALS, and many more.

Hilton San Francisco Union Square
San Francisco USA

Biotech Showcase™ is the investor conference that drives the future of drug development. Showcase your company to life science investors and strategic partners during the industry’s most important annual gathering.

Westin St. Francis Hotel
San Francisco USA

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Marines’ Memorial Club & Hotel
San Francisco USA

RESI San Francisco has become the key venue to meet early stage investors and companies during the annual January healthcare conference week. Millions upon millions of dollars have been invested in early stage companies following a connection at RESI SF. In January 2019, RESI SF’s partnering system was booked to capacity, with early stage companies and investors – 1200 attendees in total – connecting all day both in scheduled and ad hoc meetings. LSN will be launching the 2020 RESI calendar with RESI SF on January 14th at the Marine’s Memorial Club and Hotel.

Berlin Germany

The Global Forum for Food and Agriculture (GFFA) is an international conference on agri-food policy issues. Over three days at the GFFA, approx. 2,000 international visitors from politics, industry, science and civil society discuss a key topic. In addition, the world’s largest informal Conference of Agriculture Ministers takes place on the third conference day as the highlight of the GFFA. Approximately 70 ministers of agriculture from around the world and high-level representatives of international organisations adopt a joint political communiqué on the respective key topic. The GFFA is held in Berlin in parallel with the International Green Week.

Hyperion Hotel
Basel Switzerland

Achieving excellence with R&D data will enable the life sciences industry to increase the speed and quality of innovation and is thus a major source of competitive advantage. Whether researchers and informaticians deal with “big data,” “deep data” or just put their data to smarter use, it is clear that the future of R&D is dependent on both smart technologies and clever researchers. The rapid progress of innovation in software and powerful hardware now allows human researchers to interpret masses of raw data in unique ways and is redefining the R&D business model. The benefits range from discovery and “omics” research, through to clinical trials and to real patients in the real-world. However, it is major technical, financial, and operational challenge is to turn “messy” data into structured data, that can be used for advanced analytics that can spot opportunities and achieve true insights. Some of the most promising areas of technological innovation making rapid progress include, for example, artificial intelligence, machine learning, cloud computing and the blockchain (distributed ledgers). There is also huge potential for efficient collaborations between the life science industry, technology companies, academic researchers, health systems, physicians, and health insurers to remove data silos. A deeper convergence between key stakeholders and advanced technologies will facilitate the discovery and development of powerful therapies, devices and advanced diagnostics to benefit patients. The “R&D Data Intel Leaders Forum” is the must attend event for those senior decision-makers, researchers, data scientists and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D specific decision-making and intelligence.

Nice France

AgeingFit is the first European event dedicated to innovation in the Healthy Ageing sector. The next edition of AgeingFit will be held on January 28th and 29th, 2020, in Nice (France) and will gather over 600 international attendees from more than 20 countries. For its 4th edition, AgeingFit will gather healthy ageing companies, service providers, accommodation and care facilities, private and public research institutes, specialized associations and clusters, investors, health insurance providers, legislators and institutions… Their goal? Fostering business, research and financial partnerships with the objective to launch innovative products and services to the senior market.

Radison Airport Hotel
Zürich Switzerland

WHAT IS SWISS NORDIC BIO?

Swiss Nordic Bio is an investor and partnering conference connecting leading Nordic and Swiss healthcare companies with European investors. For more information about the event please visit www.swissnordicbio.com or contact us.

WHAT IS NEW 2020?

Swiss Nordic Bio 2020 = Publicly listed + Private. With Vator Securities, Swiss Nordic Bio will transform to the leading small & midcap healthcare conference and include the best publicly listed small & midcap healthcare companies, alongside exciting new start-ups in the field.